In each case, the pattern is clear : ICER tends to approve (or say value for money) only at higher price points, while NICE often demands a lower effective price to say yes. Patients in each system may end up with the same effective coverage (assuming deals are struck), but the distribution of payment is shifted
For GLP-1 medications specifically, the data is largely observational and case-based at this point
There are other tools in the metabolic health toolkit. As with correctly using so many innovations in beauty and wellness, it comes down to education
Most people do not get enough fiber from food alone, and that can affect digestion, regularity, and how you feel day to day
Benzyl Alcohol as a Preservative in Intrathecal Drug Products
Effects of a dietary supplement on cholesterol in subjects with moderate hypercholesterolemia